1. Home
  2. CURR vs ARMP Comparison

CURR vs ARMP Comparison

Compare CURR & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Currenc Group Inc. Ordinary Shares

CURR

Currenc Group Inc. Ordinary Shares

HOLD

Current Price

$1.46

Market Cap

112.6M

ML Signal

HOLD

Logo Armata Pharmaceuticals Inc.

ARMP

Armata Pharmaceuticals Inc.

HOLD

Current Price

$6.91

Market Cap

125.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CURR
ARMP
Founded
2013
N/A
Country
Singapore
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
112.6M
125.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CURR
ARMP
Price
$1.46
$6.91
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$3.50
$12.00
AVG Volume (30 Days)
224.6K
58.2K
Earning Date
11-01-2025
03-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$40,227,053.00
$5,054,000.00
Revenue This Year
N/A
$4.48
Revenue Next Year
$14.56
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.33
$0.90
52 Week High
$4.68
$16.34

Technical Indicators

Market Signals
Indicator
CURR
ARMP
Relative Strength Index (RSI) 35.89 55.35
Support Level $1.51 $6.12
Resistance Level $1.64 $6.37
Average True Range (ATR) 0.14 0.65
MACD 0.01 0.03
Stochastic Oscillator 16.22 61.20

Price Performance

Historical Comparison
CURR
ARMP

About CURR Currenc Group Inc. Ordinary Shares

Currenc Group Inc is a fintech pioneer dedicated to transforming financial services through artificial intelligence (AI). It empowers financial institutions with comprehensive AI solutions, including the SEAMLESS AI Call Centre and other AI-powered tools designed to reduce costs, increase efficiency, and boost customer satisfaction. The Company's digital remittance platform also enables e-wallets, remittance companies, and corporations to provide real-time, 24/7 payment services, advancing financial access across underserved communities. It generates the majority of its geographic revenue from Malaysia.

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.

Share on Social Networks: